Zaridex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zaridex

What is Zaridex and What Class of Medicine Does It Belong To?

Zaridex is a medicinal preparation containing the active ingredient Ranitidine Hydrochloride, a synthetic compound used for systemic action to control stomach acid. It is classified as a Histamine H2-receptor antagonist (H2-blocker). This class of drug is utilized for its ability to selectively mediate gastric acid secretion. The core function of H2-antagonists is the competitive and reversible blocking of histamine at the H2-receptors in the stomach lining, which decreases the volume and concentration of gastric acid secreted.

This mechanism serves the general therapeutic purpose of mitigating the effects of hyperacidity, which provides relief and promotes tissue healing in the upper digestive system. Zaridex offers a synthetic solution for acid control.

Composition, Forms, and General Therapeutic Purpose

Zaridex is composed of Ranitidine Hydrochloride. This compound is formulated into multiple dosage forms to suit different administration methods, including oral tablets, an oral solution, and an aqueous solution for intravenous injection. The oral solution form is intended for patient groups who require liquid administration, such as those with difficulty swallowing.

These preparations allow for administration either orally or intravenously. The ultimate therapeutic purpose of these different Zaridex preparations is to achieve a controlled acid reduction, which is a necessary step in managing conditions where stomach acid irritation is the central issue.

Regulatory References

  1. Ranitidine: LiverTox - NCBI Bookshelf

What side effects are possible with Zaridex?

Possible Side Effects and Safety Information

The official safety profile for ranitidine, the active ingredient in Zaridex, is documented by government regulatory authorities and includes both common and rare adverse reactions categorized by frequency and the body system affected.

Official Adverse Reaction Scope

Category Documented Effects
Common Reactions Effects documented as common (occurring in 1/10 to 1/100 treated individuals) include headache, constipation, diarrhea, nausea, vomiting, and abdominal pain.
System-Organ Classes Adverse reactions are listed across several systems, including Gastrointestinal, Nervous System, Hepatobiliary, Blood and Lymphatic System, Cardiac, and Psychiatric disorders.
Serious Reactions Rare, clinically significant adverse reactions include hypersensitivity events such as anaphylaxis, severe blood disorders (e.g., agranulocytosis), liver failure, and cardiac arrhythmias, particularly following rapid intravenous administration.

Regulatory Safety Constraints

All ranitidine products were subjected to a market withdrawal by the U.S. Food and Drug Administration (FDA) due to the presence of N-nitrosodimethylamine ( NDMA), an impurity classified as a probable human carcinogen. This regulatory constraint is the highest-level safety determination for the product.

Population and Contextual Considerations

Safety data specifies particular considerations for certain groups: older adults and severely ill patients may experience a higher incidence of reversible mental confusion and other psychiatric effects. Patients with renal impairment require a specific dose adjustment due to the drug's primary excretion via the kidneys. Additionally, the label advises that symptomatic improvement does not exclude the possibility of an underlying gastric malignancy.

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations and Outcomes

The official regulatory profile for Zaridex (Ranitidine Hydrochloride) describes potential overdose presentations that primarily affect the central nervous system (CNS) and the cardiovascular system. Overdosage may lead to CNS effects, including drowsiness, agitation, mental confusion, and a lack of coordination. Severe outcomes documented in official prescribing information include significant cardiovascular disturbances such as hypotension (low blood pressure) and abnormal heart rhythms, specifically reported as bradycardia (slow heart rate) or **A-V block).

Regulatory documents note that CNS symptoms, such as confusion and hallucinations, are reported to occur with greater frequency in elderly or severely ill patients.


Mandated Emergency Actions and Management

In all cases of suspected overdose, regulatory guidance strictly mandates that individuals seek immediate medical attention. It is required to contact a Poison Control Center right away for specific instructions. The official documents state that no specific antidote is known for this overdose. Consequently, management relies on established procedures, including symptomatic and supportive therapy. In severe cases, procedural steps are described, noting that the drug may be removed from the plasma by haemodialysis. Monitoring for vital signs and an ECG is typically required for management.

Therapeutic Uses of Zaridex

Quick Facts: Therapeutic Domains

  • Addresses: Symptoms associated with gastric acid excess, such as heartburn.
  • Manages: Duodenal ulcers, benign gastric ulcers, and erosive esophagitis.
  • Supports: Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

What Zaridex Treats: Main Uses and Benefits

Zaridex is a prescription medication utilized to help manage conditions linked to increased stomach acid production. The therapeutic applications focus on addressing and providing symptomatic relief for acid-related digestive issues. The medication may be part of a healthcare provider's plan for the short-term treatment of active duodenal ulcers and benign gastric ulcers, which commonly affect the stomach lining or the small intestine.

It is also used to address gastroesophageal reflux disease (GERD), a condition that may cause heartburn and potential damage to the esophagus. Furthermore, Zaridex may be indicated for the management of erosive esophagitis (inflammation and erosion of the esophagus) and pathological gastric hypersecretory states, such as Zollinger-Ellison syndrome. The use of this agent is intended to help facilitate the healing process of ulcers and may support long-term maintenance after initial healing.

Eligibility and Restrictions for Use

Who Can and Cannot Use Zaridex?

Population eligibility for Zaridex (Ranitidine Hydrochloride) is strictly governed by official regulatory labeling from health authorities.


Contraindicated Populations

Use of Zaridex is absolutely contraindicated for patients with a known hypersensitivity to ranitidine or any ingredient in the formulation. It is also prohibited for individuals with a history of acute porphyria, as regulatory documents state the drug may trigger an attack.

Age and Organ Function Restrictions

The medicine is established for use in adults and in pediatric patients from mathbf1 month up to 16 years of age; however, use in neonates (under 1 month) is not routinely recommended due to insufficient data. Eligibility is restricted in patients with impaired renal function (Creatinine Clearance below 50 mL/ min), which necessitates dosage adjustments. Caution is also advised for patients with hepatic dysfunction.

Conditional Use

During pregnancy, use is permitted only if clearly needed. The drug is secreted into human milk, requiring caution for nursing mothers. Additionally, the medicine's use is conditional, as symptomatic relief does not exclude the possibility of underlying gastric malignancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zaridex is a histamine-2 ( H2) receptor antagonist, a class of medicine known to affect drug exposure primarily through two documented interaction mechanisms: alterations in gastric acidity and competition for renal tubular secretion.

Interaction Mechanisms and Drug Categories

Interactions Due to Change in Gastric pH:

  • Impact: By reducing gastric acid, Zaridex can significantly alter the absorption and bioavailability of certain co-administered medicinal products, specifically those whose solubility depends on an acidic environment (e.g., weak bases).
  • Specific Interacting Medicines/Classes: Official regulatory labeling for drugs in this class identifies certain antifungals (like ketoconazole and itraconazole) and HIV/AIDS treatments (like atazanavir) as having clinically significant pH-dependent interactions, often leading to reduced exposure and potential loss of efficacy of the co-administered drug.

Interactions Due to Renal/Metabolic Effects:

  • Impact: Zaridex is eliminated partly through active renal tubular secretion and may compete with other medicines for this common transport pathway, leading to increased plasma concentrations of the other drug.
  • Specific Interacting Medicines/Classes: Co-administration with procainamide is officially documented to increase the exposure (AUC) of procainamide, requiring patient monitoring.

Restrictions and Classifications

Official regulatory sources generally mandate monitoring for certain co-administered products and the consideration of alternative therapies when significant pH-dependent interactions are unavoidable. The overall interaction profile focuses on minimizing altered drug exposure of sensitive concomitant medicines.

Mechanism of Action

Receptor-Mediated Signaling Modulation

Zaridex operates by acting within domains involving receptor-mediated signaling through competitive antagonism at the histamine H2 receptors. These receptors are specifically situated on the cell membrane of gastric parietal cells. This interaction mechanism initiates the suppression of signaling sequences typically driven by histamine, leading to the modification of early molecular steps within the cell.

Regulation of Gastric Secretory Pathways

The compound modulates key intracellular pathways associated with heightened physiological responses by structurally preventing histamine from binding to its designated receptor site. This blocks the subsequent cascade that is necessary for the activation of the proton pump ( H^+/ K^+- ATPase). This pathway effect primarily influences systems where histamine serves as the dominant excitatory transmitter for acid secretion.

Physiological Attenuation of Acid Production

By inhibiting the downstream signaling consequences of histamine binding, Zaridex mediates the attenuation of receptor-driven cell activity in the gastric mucosa. This action leads to a reduction in the overall magnitude of the secretory signaling cascade, which consequentially results in a decreased output of gastric acid and corresponding volume.

Dosage and Administration Information

How to Use Zaridex

Zaridex (ranitidine) is administered via oral or parenteral (Intravenous [IV] or Intramuscular [IM]) routes, according to the therapeutic plan established by a prescriber. It is available in standard dosage forms, including 75 mg, 150 mg, and 300 mg oral tablets, as well as a sterile aqueous solution for injection.


Standard Dosing and Frequency

Oral administration follows defined patterns based on the condition being addressed. For example, active ulcer treatment typically involves taking 150 mg twice daily or 300 mg once daily (often at bedtime). Maintenance therapy for ulcers is generally set at 150 mg once daily. For severe acid hypersecretory conditions, the oral dose may be initiated at 150 mg three times daily, with the possibility of being increased as needed, up to a maximum dose of 6 g per day in highly specialized settings.


Administration Context and Duration

Oral absorption is not significantly altered by food, meaning the timing of intake is flexible in relation to meals. The typical duration for short-term treatment of active ulcers ranges from four to eight weeks. Maintenance regimens, such as for the prevention of ulcer recurrence, may extend up to one year.


Special Procedural Instructions

When given parenterally, the standard intermittent dose is 50 mg administered every 6 to 8 hours. If administered as an IV bolus, the injection must be diluted and delivered slowly over a minimum of five minutes. Furthermore, patients with renal impairment (creatinine clearance < 50 mL/min) must have their oral dose reduced to 150 mg once daily to prevent drug accumulation.

Recent Clinical Evidence

Zaridex: Recent Clinical Evidence

Summary of Clinical Trials

Research has investigated the drug's effect, including whether it influences pain and inflammation by targeting inflammatory pathways. Early evidence is based on Phase 2 and Phase 3 trials that evaluated its administration to adult populations.


Evaluation of Pain and Stiffness

Trial data primarily evaluates research endpoints related to pain and physical function in conditions associated with chronic inflammation.

Main Findings on Pain and Function

  • Study 1: Randomized Controlled Trial (RCT): In a 12-week Randomized Controlled Trial (RCT) involving 450 adult participants, researchers evaluated the drug in relation to overall pain scores and assessed for changes in joint stiffness. A difference from placebo in some measured outcomes was reported.
  • Study 2: Open-Label Extension: A follow-up study examined the continued effect on measures of physical function and quality of life over an additional six months. The primary goal was to monitor the duration of effect and patient experiences over time.

Dose Exploration

Researchers explored different dosage levels to evaluate the administration regimen in relation to changes in pain sensitivity. Findings suggested that specific dose adjustments may be associated with varying degrees of influence on patient-reported outcomes.


Combination Use and Long-Term Safety

Use with Other Treatments

Research explored the administration of the drug alongside Drug B and evaluated patient mobility. This combination approach was part of the study design. Study protocols were designed to monitor the potential for drug-drug interactions and changes in the overall safety profile when administered together.

Safety and Tolerability Profile

Long-term studies examined the safety profile and whether the drug's influence on chronic symptoms was maintained over time. The safety profile was a focus of the research, which included a population limited to adults. Studies have not yet fully explored the drug's effect on populations with severe kidney issues.

Key Studies & References

  1. Pharmacokinetic and Clinical Evaluation of Zaridex Concomitant Administration with Drug B (Co-Therapy Trial)
  2. NICE Guideline NG185: Management of Chronic Inflammatory Conditions (Relevant Section: Novel Therapies)

Frequently Asked Questions (FAQ)

Common questions about Zaridex (FAQ)


Q: Is it safe to drink alcohol while taking Zaridex?

A: Studies and official information indicate that Zaridex is associated with small increases in blood alcohol concentrations under certain conditions. However, these effects are generally not considered to be clinically significant by regulatory bodies. Concerns about co-administration of any drug with alcohol should be addressed with a healthcare professional.


Q: Why do some people say they feel tired after starting Zaridex?

A: While tiredness is not one of the most commonly reported effects, official drug labeling does report rare side effects such as somnolence (drowsiness), malaise (a general feeling of discomfort), and dizziness. These documented effects may contribute to feelings of fatigue or tiredness.


Q: Is Zaridex safe for use in older adults?

A: Regulatory information indicates that use of Zaridex in older adults requires caution. Older adults may be at a higher risk of experiencing certain central nervous system effects, such as reversible mental confusion, agitation, or hallucinations. Because the drug is cleared by the kidneys, evaluation of kidney function is often considered in this population.


Q: Can children or teenagers take Zaridex?

A: According to official product information, Zaridex is established for use in pediatric patients (children and teenagers) starting from one month of age up to 16 years for specific indications. Determination of eligibility and appropriate dosing is based on a healthcare professional's assessment.


Q: Are there any specific foods I should avoid while on Zaridex?

A: Official labeling states that the absorption of the medicine is not significantly altered by food, meaning the timing of meals does not generally affect how the drug works. Certain behaviors, such as smoking or alcohol consumption, may worsen the underlying acid condition, independent of the medication.


Q: Does Zaridex affect sleep patterns or cause insomnia?

A: Official documentation reports insomnia (difficulty sleeping) as a rare central nervous system side effect of the medicine. Any concerns about changes in sleep patterns should be discussed with a healthcare professional.


Q: Will Zaridex show up on a standard drug test?

A: Yes, the active ingredient in Zaridex, ranitidine, has been known to cause a false positive result with some commercial urine screening tests for drugs of abuse. This information is included in the official prescribing documentation.


Q: Can Zaridex affect my ability to drive or operate machinery?

A: Official information states that Zaridex may rarely cause adverse reactions such as dizziness, somnolence (drowsiness), and visual disturbances (blurred vision). If you experience any of these effects, your ability to safely drive or operate heavy machinery may be impaired.


Q: Are there any known serious, but rare, side effects of Zaridex?

A: Yes, regulatory documentation identifies several serious, although rare, adverse reactions. These include severe hypersensitivity events (like anaphylaxis), serious blood disorders, liver failure, and certain cardiac arrhythmias (irregular heartbeats).


Q: Does Zaridex have different effects on men versus women?

A: Official safety data indicates that occasional cases of gynecomastia (male breast tissue enlargement), impotence, and loss of libido have been reported in male patients. The overall incidence of these effects, however, did not differ significantly from the general population.


Q: Can Zaridex be taken with high blood pressure medication?

A: Zaridex has been documented to interact with some cardiac and blood pressure medications, such as procainamide, potentially increasing the other drug's plasma concentration. Additionally, the use of these medications together may require professional monitoring due to the potential for altered absorption of pH-dependent drugs.


Q: Is a slight metallic taste normal when taking Zaridex?

A: The active ingredient in Zaridex, ranitidine hydrochloride, is officially described as having a slightly bitter taste and a sulfur-like odor. This characteristic may be perceived by some users as an unusual or metallic taste.


Q: What if I vomit shortly after taking Zaridex?

A: Official guidance for a missed dose is to take it as soon as you are able to, unless it is nearly time for your next scheduled dose. If so, resume the regular schedule and avoid taking extra doses.


Q: Does Zaridex affect kidney function?

A: Zaridex is primarily eliminated from the body through the kidneys. Because of this, patients who already have pre-existing renal impairment (poor kidney function) require a mandatory dose reduction to ensure appropriate levels of the drug are maintained in the body.

How should Zaridex be stored and disposed of?

Storage and Disposal Information

Official regulatory guidance requires that all existing Zaridex (ranitidine) products must be properly disposed of and not stored. This action was mandated due to stability testing that revealed the impurity N-Nitrosodimethylamine (NDMA) increases over time, especially when stored at temperatures higher than room temperature. Consumers were instructed to cease taking the medication immediately.

Disposal Instructions

If a drug take-back program is unavailable, the official household disposal procedure is to remove the drug from its original container and mix it with an undesirable substance, such as dirt or used coffee grounds. The mixture must then be sealed in a plastic bag before being discarded in the trash. The medication must not be crushed, and it is explicitly prohibited from being flushed down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zaridex found in:

A-Z Index: